2020 Q2 Form 10-Q Financial Statement

#000156459020038662 Filed on August 10, 2020

View on sec.gov

Income Statement

Concept 2020 Q2 2019 Q2 2019 Q1
Revenue $6.120M $7.424M $6.551M
YoY Change -17.56% 8.86% 12.68%
Cost Of Revenue $1.520M $3.350M $1.890M
YoY Change -54.63% 225.24% 127.71%
Gross Profit $4.600M $4.080M $4.660M
YoY Change 12.75% -29.53% -6.61%
Gross Profit Margin 75.16% 54.96% 71.13%
Selling, General & Admin $3.670M $3.698M $3.925M
YoY Change -0.76% -9.36% 12.14%
% of Gross Profit 79.78% 90.64% 84.23%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $90.00K $70.00K $80.00K
YoY Change 28.57% -12.5% 0.0%
% of Gross Profit 1.96% 1.72% 1.72%
Operating Expenses $3.750M $3.698M $3.925M
YoY Change 1.41% -11.11% 9.64%
Operating Profit $1.024M $1.570M $659.0K
YoY Change -34.78% -3.68% -53.1%
Interest Expense $170.0K $1.250M -$20.00K
YoY Change -86.4% -3225.0% -83.33%
% of Operating Profit 16.6% 79.62% -3.03%
Other Income/Expense, Net $0.00
YoY Change -100.0%
Pretax Income $1.020M $1.548M $636.0K
YoY Change -34.11% -11.54% -50.66%
Income Tax -$1.020M $54.00K $24.00K
% Of Pretax Income -100.0% 3.49% 3.77%
Net Earnings $1.032M $1.494M $612.0K
YoY Change -30.92% -11.34% -52.52%
Net Earnings / Revenue 16.86% 20.12% 9.34%
Basic Earnings Per Share $0.05 $0.02
Diluted Earnings Per Share $65.89K $0.05 $0.02
COMMON SHARES
Basic Shares Outstanding 28.75M 28.65M 28.65M
Diluted Shares Outstanding 30.96M 28.84M 28.81M

Balance Sheet

Concept 2020 Q2 2019 Q2 2019 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.230M $3.750M $1.840M
YoY Change -40.53% -21.05% 15.0%
Cash & Equivalents $2.233M $3.751M $1.836M
Short-Term Investments
Other Short-Term Assets $1.790M $650.0K $670.0K
YoY Change 175.38% 51.16% 71.79%
Inventory $609.0K $540.0K $1.530M
Prepaid Expenses
Receivables $1.900M $2.769M $1.326M
Other Receivables $800.0K $0.00 $0.00
Total Short-Term Assets $7.324M $7.714M $5.360M
YoY Change -5.06% 23.82% 35.01%
LONG-TERM ASSETS
Property, Plant & Equipment $180.0K $181.0K $1.270M
YoY Change -0.55% -4.74% 605.56%
Goodwill $5.585M $6.158M
YoY Change -9.3%
Intangibles
YoY Change
Long-Term Investments $3.360M $4.213M $2.767M
YoY Change -20.25%
Other Assets $241.0K $224.0K $220.0K
YoY Change 7.59% -10.4% -12.0%
Total Long-Term Assets $16.10M $15.27M $13.98M
YoY Change 5.44% 47.68% 34.42%
TOTAL ASSETS
Total Short-Term Assets $7.324M $7.714M $5.360M
Total Long-Term Assets $16.10M $15.27M $13.98M
Total Assets $23.43M $22.98M $19.34M
YoY Change 1.92% 38.71% 34.59%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.740M $10.85M $5.580M
YoY Change -28.66% 66.16% 19.74%
Accrued Expenses $540.0K $510.0K $530.0K
YoY Change 5.88%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $240.0K $390.0K $1.180M
YoY Change -38.46% -23.53% 100.0%
Total Short-Term Liabilities $8.520M $11.78M $7.840M
YoY Change -27.65% 34.58% -5.08%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $240.0K $340.0K
YoY Change -100.0% -61.9% -55.26%
Other Long-Term Liabilities $55.00K $530.0K $1.662M
YoY Change -89.62%
Total Long-Term Liabilities $55.00K $770.0K $1.662M
YoY Change -92.86% 22.22% 118.68%
TOTAL LIABILITIES
Total Short-Term Liabilities $8.520M $11.78M $7.840M
Total Long-Term Liabilities $55.00K $770.0K $1.662M
Total Liabilities $9.310M $13.13M $11.06M
YoY Change -29.1% 32.77% 16.05%
SHAREHOLDERS EQUITY
Retained Earnings -$276.8M
YoY Change
Common Stock $293.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $14.11M $9.853M $8.283M
YoY Change
Total Liabilities & Shareholders Equity $23.43M $22.98M $19.34M
YoY Change 1.94% 38.68% 34.59%

Cashflow Statement

Concept 2020 Q2 2019 Q2 2019 Q1
OPERATING ACTIVITIES
Net Income $1.032M $1.494M $612.0K
YoY Change -30.92% -11.34% -52.52%
Depreciation, Depletion And Amortization $90.00K $70.00K $80.00K
YoY Change 28.57% -12.5% 0.0%
Cash From Operating Activities -$710.0K $3.030M -$2.335M
YoY Change -123.43% -29.7% 752.19%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K $5.000K
YoY Change -100.0% 50.0% -91.23%
Acquisitions
YoY Change
Other Investing Activities -$80.00K -$180.0K
YoY Change -55.56%
Cash From Investing Activities -$80.00K -$210.0K -$5.000K
YoY Change -61.9% 950.0% -91.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -70.00K -900.0K -92.00K
YoY Change -92.22% -21.05% -49.45%
NET CHANGE
Cash From Operating Activities -710.0K 3.030M -2.335M
Cash From Investing Activities -80.00K -210.0K -5.000K
Cash From Financing Activities -70.00K -900.0K -92.00K
Net Change In Cash -860.0K 1.920M -2.432M
YoY Change -144.79% -39.05% 374.07%
FREE CASH FLOW
Cash From Operating Activities -$710.0K $3.030M -$2.335M
Capital Expenditures $0.00 -$30.00K $5.000K
Free Cash Flow -$710.0K $3.060M -$2.340M
YoY Change -123.2% -29.33% 606.95%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q4 us-gaap Common Stock Value
CommonStockValue
293000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-273474000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
21917000
CY2019Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2019Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2019Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
568
CY2019Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
568
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29339101
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29339101
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
221000
CY2019Q4 us-gaap Notes And Loans Receivable Net Noncurrent
NotesAndLoansReceivableNetNoncurrent
1366000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
1483000
CY2019Q4 us-gaap Equity Method Investments
EquityMethodInvestments
2516000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
10361000
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
13975000
CY2019Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3698000
CY2019Q4 us-gaap Preferred Stock Value
PreferredStockValue
6000
CY2020Q2 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
3257000
CY2020Q2 us-gaap Goodwill
Goodwill
5585000
CY2020Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
241000
CY2020Q2 us-gaap Notes And Loans Receivable Net Current
NotesAndLoansReceivableNetCurrent
793000
CY2020Q2 us-gaap Inventory Net
InventoryNet
609000
CY2020Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1787000
CY2020Q2 us-gaap Assets Current
AssetsCurrent
7324000
CY2020Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
180000
CY2019Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
285099000
CY2020Q2 us-gaap Assets
Assets
23425000
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
7739000
CY2020Q2 us-gaap Unsecured Debt Current
UnsecuredDebtCurrent
240000
CY2019Q4 us-gaap Liabilities
Liabilities
10070000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7138000
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7623000
CY2019Q2 us-gaap Depreciation And Amortization
DepreciationAndAmortization
76000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
180000
us-gaap Depreciation And Amortization
DepreciationAndAmortization
152000
CY2020Q2 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
1601000
CY2020Q2 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
55000
CY2020Q2 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-77000
CY2020Q2 us-gaap Stockholders Equity
StockholdersEquity
14113000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
11847000
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23425000
CY2020Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
10.00
CY2020Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
568
CY2020Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
568
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
CY2019Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.05
us-gaap Costs And Expenses
CostsAndExpenses
13015000
CY2019Q2 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1269000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
182000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1269000
CY2019Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
1570000
us-gaap Operating Income Loss
OperatingIncomeLoss
1118000
us-gaap Operating Income Loss
OperatingIncomeLoss
2229000
CY2019Q2 hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
22000
hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
35000
CY2019Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1548000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1083000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
2184000
CY2019Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-994000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
78000
CY2019Q2 us-gaap Net Income Loss
NetIncomeLoss
1494000
us-gaap Net Income Loss
NetIncomeLoss
2077000
us-gaap Net Income Loss
NetIncomeLoss
2106000
CY2019Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653278
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28760893
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
28653278
CY2019Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
28842509
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30630713
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
29017377
CY2019Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.05
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.07
hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-241000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
831000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
169000
hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
0
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-170000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-495000
hgbl Noncash Lease Expense
NoncashLeaseExpense
235000
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29421456
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29421456
CY2019Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7424000
CY2019Q2 us-gaap Costs And Expenses
CostsAndExpenses
7123000
us-gaap Costs And Expenses
CostsAndExpenses
9425000
hgbl Interest And Other Expense Net
InterestAndOtherExpenseNet
45000
CY2020Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
-2000
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
75000
CY2020Q1 us-gaap Net Income Loss
NetIncomeLoss
38000
CY2020Q1 us-gaap Stockholders Equity
StockholdersEquity
11958000
CY2020Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
30000
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
86000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
7600000
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
71000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
612000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
8283000
CY2019Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
76000
CY2019Q2 us-gaap Stockholders Equity
StockholdersEquity
9853000
us-gaap Profit Loss
ProfitLoss
2077000
us-gaap Profit Loss
ProfitLoss
2106000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
48000
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
0
hgbl Noncash Lease Expense
NoncashLeaseExpense
258000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1229000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
0
us-gaap Share Based Compensation
ShareBasedCompensation
161000
us-gaap Share Based Compensation
ShareBasedCompensation
147000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
43000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2369000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
505000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-1865000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1032000
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
47000
hgbl Increase Decrease In Lease Liabilities
IncreaseDecreaseInLeaseLiabilities
-246000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-377000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
112000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
58000
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
0
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-827000
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
686000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5000
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
40000
us-gaap Payments To Acquire Equity Method Investments
PaymentsToAcquireEquityMethodInvestments
365000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
188000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
4490000
us-gaap Payments To Acquire Notes Receivable
PaymentsToAcquireNotesReceivable
0
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
662000
us-gaap Proceeds From Collection Of Notes Receivable
ProceedsFromCollectionOfNotesReceivable
0
hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
4997000
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior year balances within the condensed consolidated financial statements have been reclassified to conform to the current year presentation.</p>
hgbl Cash Received On Transfer Of Notes Receivable To Partners
CashReceivedOnTransferOfNotesReceivableToPartners
0
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
502000
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-217000
hgbl Proceeds From Issuance Of Common Stock From Stock Option Awards
ProceedsFromIssuanceOfCommonStockFromStockOptionAwards
28000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
5625000
us-gaap Proceeds From Short Term Debt
ProceedsFromShortTermDebt
500000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
5823000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
1486000
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-986000
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-517000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2728000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
4268000
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2233000
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
3751000
us-gaap Income Taxes Paid
IncomeTaxesPaid
39000
us-gaap Income Taxes Paid
IncomeTaxesPaid
94000
us-gaap Interest Paid Net
InterestPaidNet
35000
us-gaap Interest Paid Net
InterestPaidNet
32000
us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates include the assessment of collectability of revenue recognized, and the valuation of accounts receivable, inventory, other assets, right-of-use assets, goodwill and intangible assets, liabilities, deferred income tax assets and liabilities, and stock-based compensation. These estimates have the potential to significantly impact the Company&#8217;s consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.</p>
CY2019Q2 us-gaap Sale Leaseback Transaction Date
SaleLeasebackTransactionDate
The purchase option for both the real estate and machinery and equipment can be exercised at any time on or after December 1, 2019 and before May 31, 2021.
CY2019Q2 us-gaap Sale Leaseback Transaction Net Book Value
SaleLeasebackTransactionNetBookValue
20000000
CY2020Q2 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
1400000
CY2019Q4 us-gaap Impaired Financing Receivable Unpaid Principal Balance
ImpairedFinancingReceivableUnpaidPrincipalBalance
2700000
us-gaap Notes Issued1
NotesIssued1
4500000
us-gaap Proceeds From Sale Of Notes Receivable
ProceedsFromSaleOfNotesReceivable
700000
CY2020Q2 hgbl Deferred Fees And Costs
DeferredFeesAndCosts
100000
CY2020Q2 hgbl Closing Amount Of Revolving Credit Facility
ClosingAmountOfRevolvingCreditFacility
6000000
CY2020Q1 hgbl Notes Receivable Balance Of Certain Loans Transferred To Partner
NotesReceivableBalanceOfCertainLoansTransferredToPartner
1000000
CY2020Q1 hgbl Notes Receivable Balance Of Certain Loans Transferred To Joint Venture
NotesReceivableBalanceOfCertainLoansTransferredToJointVenture
3000000
CY2020Q2 hgbl Notes Receivable Balance Of Certain Loans Transferred To Joint Venture
NotesReceivableBalanceOfCertainLoansTransferredToJointVenture
1000000
CY2020Q2 us-gaap Impaired Financing Receivable With No Related Allowance Recorded Investment
ImpairedFinancingReceivableWithNoRelatedAllowanceRecordedInvestment
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
127025
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3611850
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
329750
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
106425
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
127025
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
3708150
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2143161
CY2019Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.46
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.21
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.46
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.64
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.57
CY2020Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.46
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
The Company's Class N preferred shares, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2020Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
CY2020Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
2209572
CY2019Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
189231
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
1869820
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
364099
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
700000
CY2020Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
200000
CY2019Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
600000
hgbl Number Of Locations
NumberOfLocations
3
CY2020Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
1278000
CY2019Q1 hgbl Lessee Operating Lease Incremental Borrowing Rate
LesseeOperatingLeaseIncrementalBorrowingRate
0.0525
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
us-gaap Operating Lease Expense
OperatingLeaseExpense
300000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
304000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
385000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
278000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
218000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
176000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
30000
CY2020Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
1391000
CY2020Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
113000
CY2019Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
955000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
135000
CY2020Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
820000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
100000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
134000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
270000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
159000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
129000
CY2020Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
128000
us-gaap Goodwill Period Increase Decrease
GoodwillPeriodIncreaseDecrease
0
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2019Q4 us-gaap Loans Payable
LoansPayable
438000
CY2020Q2 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
82100000
hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
Substantially all of the net operating loss carry forwards expire between 2024 and 2037.
us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
100000
CY2020Q2 hgbl Additional Deferred Tax Assets Realizable Amount
AdditionalDeferredTaxAssetsRealizableAmount
1300000

Files In Submission

Name View Source Status
0001564590-20-038662-index-headers.html Edgar Link pending
0001564590-20-038662-index.html Edgar Link pending
0001564590-20-038662.txt Edgar Link pending
0001564590-20-038662-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
gmu2pn50ett5000001.jpg Edgar Link pending
hgbl-10q_20200630.htm Edgar Link pending
hgbl-20200630.xml Edgar Link completed
hgbl-20200630.xsd Edgar Link pending
hgbl-20200630_cal.xml Edgar Link unprocessable
hgbl-20200630_def.xml Edgar Link unprocessable
hgbl-20200630_lab.xml Edgar Link unprocessable
hgbl-20200630_pre.xml Edgar Link unprocessable
hgbl-ex311_8.htm Edgar Link pending
hgbl-ex312_9.htm Edgar Link pending
hgbl-ex321_6.htm Edgar Link pending
hgbl-ex322_7.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending